Advanced Manufacturing FDI Surges as India, Germany, and Singapore Secure Billions in Tech and Biologics

Global advanced manufacturing is experiencing a significant wave of foreign direct investment (FDI) as multinational corporations and governments prioritize supply chain resilience. Recent capital commitments across Asia and Europe highlight a strategic focus on securing production capacity in critical sectors, including semiconductors, consumer electronics, and biotechnology.

Foxconn (Hon Hai Precision Industry) has announced an additional $1.5 billion investment in its Indian subsidiaries, according to Reuters. The capital will be directed toward expanding manufacturing capacity at facilities in Karnataka and Tamil Nadu. Bloomberg and The Economic Times report that this move is designed to meet the growing demand for consumer electronics and further diversify Foxconn’s global supply chain. The expansion aligns with India’s Production Linked Incentive (PLI) scheme, which seeks to boost domestic electronics manufacturing.

Simultaneously, Europe is advancing its semiconductor manufacturing capabilities. Bloomberg reports that the European Commission has approved a €5 billion German state aid measure to support a new semiconductor plant in Dresden. The facility will be built by the European Semiconductor Manufacturing Company (ESMC), a joint venture led by TSMC alongside partners Bosch, Infineon, and NXP. According to Reuters and the European Commission Press Release, the total investment for the project is estimated at €10 billion, aimed at strengthening the resilience of Europe’s semiconductor supply chain.

In Southeast Asia, Singapore continues to attract high-value manufacturing capital. The Wall Street Journal reports that Singapore’s Economic Development Board (EDB) has announced over $1.2 billion in new foreign direct investment from several global pharmaceutical and biotechnology firms. According to Bloomberg and Channel NewsAsia, this capital will fund the construction of advanced biologics manufacturing plants and research facilities. The investment leverages Singapore’s robust intellectual property framework and highly skilled workforce to expand its role in global healthcare supply chains.

These developments highlight a broader trend where multinational corporations are diversifying their manufacturing footprints to mitigate geopolitical and operational risks. By expanding in India and Singapore, companies are leveraging local incentives and strong regulatory frameworks to build resilient hubs. Meanwhile, the EU’s approval of state aid for ESMC demonstrates how government subsidies are playing a pivotal role in attracting high-tech capital. For global trade, these investments suggest a more geographically distributed production landscape, though businesses must navigate complex regulatory environments and state-aid rules to capitalize on these opportunities.